1. Steensam DP, Bennett JM. The myelodysplastic syndromes: diagnosis and treatment. Mayo Clin Proc 2006;81:104-130.
2. List AF, Vardiman J, Issa JP, DeWitte TM. Myelodysplastic syndrome. Hematology Am Soc Hematol Educ Program 2004;297-317.
3. Noel P, Solberg LA Jr. Myelodysplastic syndromes. Pathogenesis, diagnosis and treatment. Crit Rev Oncol Hematol 1992;12:193-215.
4. Nishino HT, Chang CC. Myelodysplastic syndromes: clinicopathologic features, pathobiology, and molecular pathogenesis. Arch Pathol Lab Med 2005;129:1299-1310.
5. Bennet JM, Komrokji RS. The myelodysplastic syndrome: diagnosis, molecular biology and risk assessment. Hematology 2005;10:suppl 1. 258-269.
6. Brunning RD, Head D, et al. In: Jaffe S, Harris NL, et al, editor. Myelodysplastic syndromes. World Health Organization Classification of Tumors; Tumors of Haematopoietic and Lymphoid Tissues74 2001;Lyon: IARC press. 61-74.
7. Korean Society of Hematology. Hematology 2006;1st ed. Seoul: E-Public. 265-275.